US 10,376,570 B2
OmpA and ASP14 in vaccine compositions and as diagnostic targets
Jason A. Carlyon, Richmond, VA (US)
Assigned to VIRGINIA COMMONWEALTH UNIVERSITY, Richmond, VA (US)
Filed by Virginia Commonwealth University, Richmond, VA (US)
Filed on May 17, 2018, as Appl. No. 15/981,950.
Application 15/981,950 is a division of application No. 15/477,137, filed on Apr. 3, 2017, granted, now 10,039,815.
Application 15/477,137 is a division of application No. 14/967,687, filed on Dec. 14, 2015, abandoned.
Application 14/967,687 is a division of application No. 14/408,760, granted, now 9,248,174, issued on Feb. 2, 2016, previously published as PCT/US2013/047325, filed on Jun. 24, 2013.
Claims priority of provisional application 61/698,979, filed on Sep. 10, 2012.
Claims priority of provisional application 61/665,223, filed on Jun. 27, 2012.
Prior Publication US 2018/0264097 A1, Sep. 20, 2018
Int. Cl. A61K 39/02 (2006.01); A61K 39/40 (2006.01); C07K 16/12 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01)
CPC A61K 39/0233 (2013.01) [A61K 39/40 (2013.01); C07K 16/1246 (2013.01); G01N 33/56911 (2013.01); G01N 33/56983 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/6081 (2013.01); A61K 2039/70 (2013.01); C07K 2317/76 (2013.01); G01N 2333/195 (2013.01); G01N 2333/29 (2013.01); G01N 2469/10 (2013.01); G01N 2800/42 (2013.01); Y02A 50/403 (2018.01)] 5 Claims
 
1. A method of treating a subject from an Anaplasma phagocytophilum infection comprising administering to said subject an immunogenic composition having at least one polypeptide comprising SEQ ID NO: 03 or SEQ ID NO: 06.